date name shares transaction value  carl spana president and ceo director    award at  per share   stephen t wills executive vp and cfocoo    award at  per share   john k a prendergast director    award at  per share   robert k deveer director    award at  per share   joseph stanley hull director    award at  per share   alan w dunton director    award at  per share   angela rossetti director    award at  per share   arlene m morris director    award at  per share   carl spana president and ceo director    derivativenonderivative trans at  per share   stephen t wills executive vp and cfocoo    derivativenonderivative trans at  per share   carl spana president and ceo director    derivativenonderivative trans at  per share   stephen t wills executive vp and cfocoo    derivativenonderivative trans at  per share   carl spana president and ceo director    award at  per share   stephen t wills executive vp and cfocoo    award at  per share   stephen t wills executive vp and cfocoo    award at  per share   carl spana president and ceo director    award at  per share   stephen t wills executive vp and cfocoo    award at  per share   carl spana president and ceo director    derivativenonderivative trans at  per share   stephen t wills executive vp and cfocoo    derivativenonderivative trans at  per share   carl spana president and ceo director    derivativenonderivative trans at  per share   stephen t wills executive vp and cfocoo    derivativenonderivative trans at  per share   carl spana president and ceo director    derivativenonderivative trans at  per share   stephen t wills executive vp and cfocoo    derivativenonderivative trans at  per share   carl spana president and ceo director    derivativenonderivative trans at  per share   stephen t wills executive vp and cfocoo    derivativenonderivative trans at  per share   john k a prendergast director    derivativenonderivative trans at  per share   robert k deveer director    derivativenonderivative trans at  per share   joseph stanley hull director    derivativenonderivative trans at  per share   alan w dunton director    derivativenonderivative trans at  per share   angela rossetti director    derivativenonderivative trans at  per share   arlene m morris director    derivativenonderivative trans at  per share   john k a prendergast director    award at  per share   robert k deveer director    award at  per share   joseph stanley hull director    award at  per share   alan w dunton director    award at  per share   angela rossetti director    award at  per share   arlene m morris director    award at  per share   carl spana president and ceo director    award at  per share   stephen t wills executive vp and cfocoo    award at  per share   john k a prendergast director    award at  per share   robert k deveer director    award at  per share   joseph stanley hull director    award at  per share   alan w dunton director    award at  per share   zola p horovitz director    award at  per share   angela rossetti director    award at  per share   arlene m morris director    award at  per share   joseph stanley hull director    acquisition at  per share   joseph stanley hull director    acquisition at  per share  newslatestcompanyusptn marketwatch news on ptn three healthcare deals today are paying huge premiums  am march    philip van doorn astrazeneca halts development of antiobesity drug  am sept    marketwatchcom palatinastrazeneca obesitydrug trial halted  am june    marketwatchcom newsnonmarketwatchcompanyusptn other news on ptn valeant pharmaceuticals intl inc vrx stock isn’t healed by paulson’s presence  pm june    investorplacecom palatin technologies ptn ceo dr carl spana on q  results  earnings call transcript  pm may    seeking alpha q palatin technologies inc  pm may    edgar online  edg  q k amag pharma amag incurs loss in q revenues rise yy  am may    zackscom dicerna pharmaceuticals drna rises stock climbs   am feb    zackscom amag pharma amag incurs loss in q revenues lag estimates  am feb    zackscom palatin technologies has great upside potential  am feb    seeking alpha q palatin technologies inc  pm feb    edgar online  edg  q k palatin technologies ptn ceo carl spana on q  results  earnings call transcript  pm feb    seeking alpha palatin closes rekynda license deal with amag pharma shares ahead  premarket  am feb    seeking alpha palatin ptn sees hammer chart pattern time to buy  am feb    zackscom amag palatin ink deal to focus on female sexual disorder  am jan    zackscom why amag pharmaceuticals inc is falling today  pm jan    motley fool palatin technologies market misunderstanding creates  upside  pm dec    seeking alpha palatin tech prices equity offering shares down  premarket  am dec    seeking alpha palatin technologies ptn ceo carl spana on q  results  earnings call transcript  pm nov    seeking alpha q palatin technologies inc  pm nov    edgar online  edg  q k palatins female sexual function drug succeeds offers large upside  pm nov    seeking alpha female viagra developer palatin tech exploring potential sale shares up   am nov    seeking alpha fda issues draft guidance for developers of femaledesire drugs  am oct    seeking alpha loading more headlines at a glance palatin technologies inc cedar brook corporate center b cedar brook drive cranbury new jersey  phone   industry biotechnology sector health carelife sciences fiscal yearend  view sec filings revenue na net income m employees  annual report for ptn newspressreleasecompanyusptn press releases on ptn daily technical summary reports on healthcare stocks  valeant pharma palatin technologies amag pharma and idexx labs  am july    pr newswire  prf stock performance review on healthcare sector  palatin technologies centene anthem and amag pharma  am june    pr newswire  prf palatin technologies inc reports third quarter fiscal year  results teleconference and webcast to be held on may    am may    pr newswire  prf palatin technologies inc to report third quarter fiscal year  results teleconference and webcast to be held on may    am may    pr newswire  prf research reports initiation on diagnostic substances stocks  palatin technologies amag pharma idexx labs and meridian bioscience  am april    pr newswire  prf palatin technologies to present at the microcap conference on april th at  pm et in new york city at the essex house  pm march    accesswire palatin technologies receives notice of allowance on bremelanotide methods of use patent for treatment of hypoactive sexual desire disorder in premenopausal women  am march    pr newswire  prf healthcare stocks on investors radar  delcath systems palatin technologies amag pharma and idexx laboratories  am march    pr newswire  prf palatin technologies to present at the th annual roth conference  pm march    pr newswire  prf amag and palatin announce rekyndatm data presentations at the international society for the study of womens sexual health annual meeting  am feb    globenewswire palatin technologies inc reports second quarter fiscal year  results teleconference and webcast to be held on february    am feb    pr newswire  prf research reports initiation on healthcare stocks  palatin technologies amag pharma idexx labs and delcath systems  am feb    pr newswire  prf palatin technologies announces closing of license agreement with amag pharmaceuticals for north american rights to rekynda™  am feb    pr newswire  prf palatin technologies to hold call following closing of licensing agreement for north american rights to rekynda™  pm jan    pr newswire  prf diagnostic substances stocks on investors radar  palatin technologies amag pharma nymox pharma and idexx laboratories  am dec    pr newswire  prf palatin technologies closes on  million financing  pm dec    pr newswire  prf palatin technologies announces pricing of public offering of common stock and warrants  am dec    pr newswire  prf palatin technologies announces proposed public offering of common stock and warrants  pm nov    pr newswire  prf peptide therapeutics in metabolic disorders     am nov    pr newswire  prf palatin technologies inc to report first quarter fiscal year  results teleconference and webcast to be held on november    am nov    pr newswire  prf loading more headlines trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite tlt quoteszigmancomposite jnug x powered by log in  pm edt july   marketstatecountryus new york after marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest pjonathan golub leaves rbc to head equities strategy at credit suisse report pamazon earnings forecast shows spending expected to continue pa quarter of sp ’s  climb due to five stocks yes those five pnuvasive shares drop after announced coo cfo departures pboston beer jumps on stellar secondquarter earnings pdow ends at record but tech slump weighs on sp  nasdaq pamazon earnings fall  shares drop pelectronic arts shares fall after firstquarter results prevolution investing and the halftrilliondollar club pfirst solar shares jump  on big earnings beat strong outlook ptreasury yields rebound on raft of solid economic data and att debt deal pwhy millions are locked out of the american dream and you may not have to take your antibiotics pstarbucks adj earnings above expectations teavana stores to close pdan neil drives vws atlas ptrump today president cites ‘big progress’ on gangs as sessions says he’ll stay in job pelectronic arts q revenue  million vs  million pelectronic arts q factset eps gaap consensus  pboeings stock surge helps dow industrials log a record and avoid a techfueled drop pelectronic arts q eps  vs  pmattel shares slip after results fall short of street view loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  palatin technologies inc ptn company profile  reuterscom x edition united states africa américa latina عربي argentina brasil canada  deutschland españa france india italia  méxico россия united kingdom united states profile palatin technologies inc ptn related topics stocksstock screenerhealthcarebiotechnology  medical research overview news key developments people charts financials analysts research pulse ptn on american stock exchange usd  jul  change  chg   prev close  open  days high  days low  volume  avg vol  wk high  wk low  full description palatin technologies inc incorporated on november   is a biopharmaceutical company the company is engaged in developing targeted receptorspecific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential its programs are based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems the companys primary product in clinical development is bremelanotide for the treatment of premenopausal women with hypoactive sexual desire disorder hsdd which is a type of female sexual dysfunction fsd defined as low desire with associated distress its other drug development programs include melanocortin receptor mcr pl and melanocortin receptor mcr in addition it has drug candidates or development programs for obesity erectile dysfunction cardiovascular diseases pulmonary diseases inflammatory diseases and dermatologic diseasesbremelanotidebremelanotide is a melanocortin agonist a synthetic peptide analog of a naturally occurring hormone called alphamsh the mechanism of action involves helping to activate internal pathways involved in the bodys normal sexual responses bremelanotide is in phase iii clinical trials for a type of fsd with decreased sexual desire that is also known as hsddmelanocortin receptormcr is a compound used for treatment of obesity and diabetes the company is engaged in preclinical activities with mcr compounds and is evaluating pharmaceutical applications it has selected an internal lead compound for obesity designated pl which has over fold functional selectivity for mcr over mcr with minimal effect on blood pressure and limited central nervous system penetrationplthe companys heart failure product candidate is pl pl is a subcutaneously injected guanylatecyclase type a gca receptor agonist it is in development for patients with heart failure to reduce the risk of cardiovascular death and hospitalization pl is also being developed for heart failure patients with a lossoffunction corin mutation or other clinically meaningful natriuretic peptide system deficiencies a patient population that is particularly resistant to the current standard of care its heart failure program is focused on the natriuretic peptide receptor system it is developing synthetic mimetics of natural neuropeptide hormones including mimetics of atrial natriuretic peptide and other natriuretic peptidesmelanocortin receptormcr agonist peptides are used for treatment of inflammatory and dermatologic disease indications the company is conducting preclinical animal studies with its mcr peptide drug candidates for various indications primarily inflammatory diseaserelated and autoimmune indications the mcr is upregulated in various diseases including inflammatory bowel disease nephritis inflammation of the kidneys rheumatoid arthritis ocular indications such as uveitis and dry eye and dermatologic indications » full overview of ptn company address palatin technologies inc b cedarbrook drcranbury   nj    p f  company web links home page officers  directors name compensation john prendergast  carl spana  stephen wills  robert deveer  alan dunton  » more officers  directors palatin technologies inc news » more ptn news related topics stocksstock screenerhealthcarebiotechnology  medical research palatin technologies inc  product pipeline review   infowiseguyreportscom     chat with us           us         uk login register home report categories premium reports access to  premium reports aerospace  defense agri  food automotive basic materials consumer goods  retail energy life sciences manufacturing  construction services telecom  it education security  intelligence systems technology company reports report categories aerospace  defense agri  food automotive basic materials consumer goods  retail energy life sciences manufacturing  construction services telecom  it education security  intelligence systems technology company reports publisher knowledgestore countries browse by country browse by continent browse by group  region conferences upcoming conferences seminars conferences upcoming conferences seminars countries browse by country browse by continent browse by group  region news  blog press release blog news  blogs press release blogs faqs about us about our company our team life at wgr careers contact us there are no items currently in your basket there are no items currently in your basket search home all reports palatin technologies inc  product pipeline review   palatin technologies inc  product pipeline review   wgr  january  global  pages global markets direct description table of content sample report enquiry before buy related reports palatin technologies inc  product pipeline review  summaryglobal market direct’s pharmaceuticals report “palatin technologies inc  product pipeline review  ” provides data on the palatin technologies inc’s research and development focus the report includes information on current developmental pipeline complete with latest updates and features on discontinued and dormant projects this report is built using data and information sourced from global markets direct’s proprietary databases palatin technologies inc’s corporate website sec filings investor presentations and featured press releases both from palatin technologies inc and industryspecific third party sources put together by global markets direct’s team scope palatin technologies inc  brief palatin technologies inc overview including business description key information and facts and its locations and subsidiaries review of current pipeline of palatin technologies inc human therapeutic division overview of pipeline therapeutics across various therapy areas coverage of current pipeline molecules in various stages of drug development including the combination treatment modalities across the globe product profiles for late stage and clinical stage products of palatin technologies inc with complete description of the product’s developmental history mechanism of action therapeutic class target and major milestones  recent updates of the palatin technologies inc’s pipeline in the last quarter  key discontinued and dormant projects  latest news and deals relating to the productsreasons to buy evaluate palatin technologies inc’s strategic position with total access to detailed information on its product pipeline  assess the growth potential of palatin technologies inc in its therapy areas of focus  identify new drug targets and therapeutic classes in the palatin technologies inc’s rd portfolio and develop key strategic initiatives to reinforce pipeline in those areas  exploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gaps  exploit collaboration and partnership opportunities with palatin technologies inc  avoid intellectual property rights related issues  explore the dormant and discontinued projects of palatin technologies inc and identify potential opportunities in those areas table of contentstable of contents list of tables list of figures palatin technologies inc snapshot palatin technologies inc overview key information key facts palatin technologies inc  research and development overview key therapeutic areas palatin technologies inc  pipeline review pipeline products by stage of development pipeline products  monotherapy palatin technologies inc  pipeline products glance palatin technologies inc  clinical stage pipeline products phase ii productscombination treatment modalities palatin technologies inc  early stage pipeline products preclinical productscombination treatment modalities discovery productscombination treatment modalities palatin technologies inc  unknown stage pipeline products unknown productscombination treatment modalities palatin technologies inc  drug profiles bremelanotide product description mechanism of action rd progress pl product description mechanism of action rd progress melanocortin receptor peptides product description mechanism of action rd progress pl product description mechanism of action rd progress drug for cachexia product description mechanism of action rd progress next generation melanocortin receptor specific peptide product description mechanism of action rd progress palatin technologies inc  pipeline analysis palatin technologies inc  pipeline products by therapeutic class palatin technologies inc  pipeline products by target palatin technologies inc  pipeline products by route of administration palatin technologies inc  pipeline products by molecule type palatin technologies inc  pipeline products by mechanism of action palatin technologies inc  recent pipeline updates palatin technologies inc  discontinued pipeline products discontinued pipeline product profiles bremelanotide palatin technologies inc  company statement palatin technologies inc  locations and subsidiaries head office other locations  subsidiaries appendix methodology coverage secondary research primary research expert panel validation contact us disclaimer list of tablespalatin technologies inc key information palatin technologies inc key facts palatin technologies inc  pipeline by indication  palatin technologies inc  pipeline by stage of development  palatin technologies inc  monotherapy products in pipeline  palatin technologies inc  phase ii  palatin technologies inc  preclinical  palatin technologies inc  discovery  palatin technologies inc  unknown  palatin technologies inc  pipeline by therapeutic class  palatin technologies inc  pipeline by target  palatin technologies inc  pipeline by route of administration  palatin technologies inc  pipeline by molecule type  palatin technologies inc  pipeline products by mechanism of action  palatin technologies inc  recent pipeline updates  palatin technologies inc  discontinued pipeline products  palatin technologies inc subsidiaries list of figurespalatin technologies inc  pipeline by top  indication  palatin technologies inc  pipeline by stage of development  palatin technologies inc  monotherapy products in pipeline  palatin technologies inc  pipeline by top  therapeutic class  palatin technologies inc  pipeline by top  target  palatin technologies inc  pipeline by top  route of administration  palatin technologies inc  pipeline by top  molecule type  palatin technologies inc  pipeline products by top  mechanism of action   request a sample report name email optional request you to please fill in your corporate emailid job title company phone no your country select country afghanistan albania algeria american samoa andorra angola anguilla antigua  barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia  herzegovina botswana brazil brunei bulgaria burkina faso burundi cambodja cameroon canada cape verde cayman islands central african republic chad chile china colombia comoros congobrazzaville congokinshasa cook islands costa rica cote divoire croatia cuba cyprus czech republic denmark djibouti dominica dominican republic ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland malvinas faroes fiji finland france frenchguiana tahitifrench polinesia gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guineabissau guyana haiti vatican city honduras hong kong hungary iceland india indonesia iran iraq ireland israel italy jamaica japan jordan kazakhstan kenya kiribati north korea south korea kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macao macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mexico micronesia moldova monaco mongolia montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria norfolk northern mariana norway oman pakistan palau panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russian federation rwanda saint helena saint lucia saint pierre and miquelon st vincent  the grenadines samoa san marino sao tome  principe saudi arabia senegal seychelles sierra leone singapore slovakia slovenia solomon islands somalia south africa spain sri lanka sudan suriname svalbard and jan mayen swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tokelau tonga trinidad  tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states of america uruguay uzbekistan vanuatu venezuela viet nam virgin islands british virgin islands us wales western sahara yemen zambia zimbabwe timorleste curacao st kitts  nevis sint maarten guernsey isle of man jersey niue montenegro do you have any specific field of interest confirm make an enquiry before buying this report name email optional request you to please fill in your corporate emailid job title company phone no your country select country afghanistan albania algeria american samoa andorra angola anguilla antigua  barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia  herzegovina botswana brazil brunei bulgaria burkina faso burundi cambodja cameroon canada cape verde cayman islands central african republic chad chile china colombia comoros congobrazzaville congokinshasa cook islands costa rica cote divoire croatia cuba cyprus czech republic denmark djibouti dominica dominican republic ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland malvinas faroes fiji finland france frenchguiana tahitifrench polinesia gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guineabissau guyana haiti vatican city honduras hong kong hungary iceland india indonesia iran iraq ireland israel italy jamaica japan jordan kazakhstan kenya kiribati north korea south korea kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macao macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mexico micronesia moldova monaco mongolia montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria norfolk northern mariana norway oman pakistan palau panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russian federation rwanda saint helena saint lucia saint pierre and miquelon st vincent  the grenadines samoa san marino sao tome  principe saudi arabia senegal seychelles sierra leone singapore slovakia slovenia solomon islands somalia south africa spain sri lanka sudan suriname svalbard and jan mayen swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tokelau tonga trinidad  tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states of america uruguay uzbekistan vanuatu venezuela viet nam virgin islands british virgin islands us wales western sahara yemen zambia zimbabwe timorleste curacao st kitts  nevis sint maarten guernsey isle of man jersey niue montenegro your enquiry confirm purchase this market research report usd gbp euro yen inr user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  add to cart buy now   email report   sample report   save page   any questions   download information   check discount   download order form   email report   sample report   save page   any questions   download information   check discount   download order form contact us akash anand domain head business development saleswiseguyreportscom     us     uk rishabh arora domain head business development saleswiseguyreportscom  abu koshy domain head business development saleswiseguyreportscom     related reports × tell a friend about this report your name your email friends name friends email your enquiry send market report palatin technologies inc  product pipeline review   about us • publishers • contact us • cart login  register all industries business  finance  business  financial services  insurance  marketing consumer  food  beverages  consumer goods  food  retailing healthcare  biotechnology  healthcare  medical devices  pharmaceuticals heavy industry  construction  energy  manufacturing  materials  transportation internet  media  ebusiness  internet  media  publishing public sector  defense  education  government telecom  computing  computer technology  fixed networks  software  wireless companycountry reports  company reports  country reports  regional reports   processing palatin technologies inc  product pipeline review   nov    global markets direct   pages  usd  click here to open the popup youve added the following report to your cartclose cart summary total items subtotal      report summary table of contents companies request details related global markets directs palatin technologies inc  product pipeline review   provides an overview of the palatin technologies incs pharmaceutical research and development focusthis report provides comprehensive information on the current therapeutic developmental pipeline of palatin technologies incs complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projectsglobal markets directs report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets directs proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets directs team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basisthe report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass productsnote certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated diseasescopethe report provides brief overview of palatin technologies inc including business description key information and facts and its locations and subsidiariesthe report reviews current pipeline of palatin technologies incs human therapeutic division and enlists all their major and minor projectsthe report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestonesspecial feature on outlicensed and partnered product portfoliothe report summarizes all the dormant and discontinued pipeline projectslatest company statementlatest news and deals relating to the palatin technologies incs pipeline productsreasons to buyevaluate palatin technologies incs strategic position with total access to detailed information on its product pipelineassess the growth potential of palatin technologies inc in its therapy areas of focusidentify new drug targets and therapeutic classes in the palatin technologies incs rd portfolio and develop key strategic initiatives to reinforce pipeline in those areasexploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gapsdevelop strategic initiatives by understanding the focus areas of palatin technologies inc and exploit collaboration and partnership opportunitiesidentify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantageplan mergers and acquisitions effectively by identifying the most promising pipeline of palatin technologies incdevelop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scopeexplore the dormant and discontinued projects of palatin technologies inc and identify potential opportunities in those areasavoid intellectual property rights related issues table of contentstable of contentslist of tableslist of figurespalatin technologies inc snapshotpalatin technologies inc overviewkey informationkey factspalatin technologies inc  research and development overviewkey therapeutic areaspalatin technologies inc  pipeline reviewpipeline products by stage of developmentpipeline products  monotherapypipeline products  outlicensed productsoutlicensed productscombination treatment modalitiespalatin technologies inc  pipeline products glancepalatin technologies inc  late stage pipeline productsphase iii productscombination treatment modalitiespalatin technologies inc  clinical stage pipeline productsphase i productscombination treatment modalitiespalatin technologies inc  early stage pipeline productspreclinical productscombination treatment modalitiesdiscovery productscombination treatment modalitiespalatin technologies inc  drug profilesbremelanotideproduct descriptionmechanism of actionrd progressplproduct descriptionmechanism of actionrd progressplproduct descriptionmechanism of actionrd progressplproduct descriptionmechanism of actionrd progresssynthetic peptide to agonize melanocortin  receptor for female sexual dysfunction and erectile dysfunctionproduct descriptionmechanism of actionrd progresssynthetic peptides to agonize npra and nprb for undisclosed indicationproduct descriptionmechanism of actionrd progresssynthetic peptides to agonize nprb for undisclosed indicationproduct descriptionmechanism of actionrd progresssynthetic peptides to target nprc for undisclosed indicationproduct descriptionmechanism of actionrd progresspalatin technologies inc  pipeline analysispalatin technologies inc  pipeline products by targetpalatin technologies inc  pipeline products by route of administrationpalatin technologies inc  pipeline products by molecule typepalatin technologies inc  pipeline products by mechanism of actionpalatin technologies inc  recent pipeline updatespalatin technologies inc  dormant projectspalatin technologies inc  discontinued pipeline productsdiscontinued pipeline product profilesbremelanotidepalatin technologies inc  company statementpalatin technologies inc  locations and subsidiarieshead officeother locations  subsidiariesappendixmethodologycoveragesecondary researchprimary researchexpert panel validationcontact usdisclaimerlist of tablespalatin technologies inc key informationpalatin technologies inc key factspalatin technologies inc  pipeline by indication palatin technologies inc  pipeline by stage of development palatin technologies inc  monotherapy products in pipeline palatin technologies inc  outlicensed products in pipeline palatin technologies inc  outlicensed products combination treatment modalities palatin technologies inc  phase iii palatin technologies inc  phase i palatin technologies inc  preclinical palatin technologies inc  discovery palatin technologies inc  pipeline by target palatin technologies inc  pipeline by route of administration palatin technologies inc  pipeline by molecule type palatin technologies inc  pipeline products by mechanism of action palatin technologies inc  recent pipeline updates palatin technologies inc  dormant developmental projectspalatin technologies inc  discontinued pipeline products palatin technologies inc subsidiarieslist of figurespalatin technologies inc  pipeline by top  indication palatin technologies inc  pipeline by stage of development palatin technologies inc  monotherapy products in pipeline palatin technologies inc  pipeline by top  target palatin technologies inc  pipeline by top  route of administration palatin technologies inc  pipeline by top  molecule type palatin technologies inc  pipeline products by top  mechanism of action  companies mentioned in this reportpalatin technologies inc this report does not have a press release associated with it order today format pdf  usd license single user delivery by email   business day the fast market research advantage only the best all of our research is sourced from the most trusted and established global analysts and consultancies client focused from startups to multinationals we focus on providing the right research to our diverse client base shop securely our usbased customer service team and ecommerce systems adhere to the highest data security standards industryleading customer support individualized assistance from our expert staff is never more than an email or phone call away best price guarantee we are committed to providing the best research at the lowest cost we will match any published price for the same report guaranteed easy ordering once you’ve found the right report click ‘order now’ and complete the checkout process using any major credit card check or wirebank transferneed multiuser or enterprise license pricing contact us for a custom quote about the publisher global markets direct is a leading provider of global business intelligence and market analysis it publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industryspecific information publisher details privacy policy  terms of use  flashalerts copyright copy  fast market research inc ptnnyse mkt llc stock quote  palatin technologies inc  bloomberg markets error could not add to watchlist x  watchlist palatin technologies inc ptnus nyse mkt llc usd   as of  pm edt  open  day range    volume  previous close  wk range     yr return  before its here its on the bloomberg terminal learn more open  day range    volume  previous close  wk range     yr return  ytd return  current pe ratio ttm  earnings per share usd ttm  market cap m usd  shares outstanding m  pricesales ttm  dividend indicated gross yield  sector health care  price change  industry pharmaceuticals biotechnology  life sciences  price change  related videos there are currently no related videos for this ticker please check back later company news press releases  amag pharmaceuticals inks m drug deal  investopedia there are currently no news stories for this ticker please check back later  erectile dysfunction pipeline drugs and therapeutics market h  available at rnr market research  mediwound announces changes to its board of directors  palatin technologies inc reports third quarter fiscal year  results teleconference and webcast to be held on may   palatin technologies inc to report third quarter fiscal year  results teleconference and webcast to be held on may    amag pharmaceuticals announces first quarter  financial results and provides corporate update  greenhill  co reports first quarter loss per share of   palatin technologies receives notice of allowance on bremelanotide methods of use patent for treatment of hypoactive sexual  palatin technologies to present at the th annual roth conference  amag and palatin announce rekynda™ data presentations at the international society for the study of women’s sexual health a  palatin technologies inc reports second quarter fiscal year  results teleconference and webcast to be held on february  there are currently no press releases for this ticker please check back later profile palatin technologies inc is a biopharmaceutical company the company researches products for the treatment of male and female sexual dysfunction congestive heart failure obesity and cachexia address c cedar brook drivecranbury nj united states phone  website wwwpalatincom executives board members carl spana presidentceocofounder stephen t wills exec vpcfocootreasurersecyir show more microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft inc palatin technologies  netfind content results aol search skip over navigation search the web web web content palatin technologies  looksmart  wwwlooksmartcom ad · wwwlooksmartcom​palatin technologies results for palatin technologies get the look smart on looksmartcom look here good results more info bremelanotide bremelanotide formerly known as pt brand name rekynda is a peptide drug candidate which has been under development by palatin technologies as a treatment for female sexual dys more go to encyclopedia  news  videos  reference source wikipedia results from the wowcom content network palatin technologies inc ptn  aolcom httpswwwaolcomstockquotesnysemktpalatintechnologiesincptn view the basic ptn stock information on aol finance and compare palatintechnologiesinc against other companies according to science your sex drive is real  huffpost wwwhuffingtonpostcomaccordingtoscienceyourbhtml according to science your sex drive is real  inc lundbeck palatin technologies pfizer inc s biopharmaceuticals inc sprout pharmaceuticals  anita h clayton md  huffpost wwwhuffingtonpostcomauthoranitahclaytonmd anita h clayton md interim chair department of psychiatry  neurobehavioral sciences  palatin technologies pfizer inc takeda trimel pharmaceuticals a look behind the bedroom door at whats causing your low  wwwhuffingtonpostcomalookbehindthebedroombhtml a look behind the bedroom door at whats causing your low libido by anita h clayton md  lundbeck naurex otsuka palatin technologies pfizer inc infosys to acquire ecommerce services provider kallidus  httpstechcrunchcominfosyskallidusskalamillion infosys to acquire ecommerce services provider kallidus  to buy digital ecommerce services provider kallidus for   technologies inc  colombia is one of latin america’s most promising new tech  httpstechcrunchcomanoverviewofcolombiaoneof search techcrunch search  the first stage of the government’s concerted campaign to rebrand colombia as a technology center involved drawing in  alanco technologies inc alan  aolcom httpswwwaolcomnasdaqotcbbalancotechnologiesincalan view the basic alan stock information on aol finance and compare alancotechnologiesinc against other companies new car technology high tech cars  autoblog wwwautoblogcomcartech see whats new in automotive technology including the hottest car gadgets latest driver assistance and navigation systems   oath inc hyperloop technologies becomes hyperloop one pulls in   httpstechcrunchcomhyperlooptechnologiesbecomes los angelesbased hyperloop technologies is now hyperloop one and  million richer from a close of its series b round of financing today techcrunch  official site httpstechcrunchcom techcrunch is a leading technology media property dedicated to obsessively profiling startups reviewing new internet products and breaking tech news palatin technologies  looksmart  wwwlooksmartcom ad · wwwlooksmartcom​palatin technologies results for palatin technologies get the look smart on looksmartcom look here good results more info searches related toinc palatin technologies palatin technologies inc rumors ptn stock prediction ptn message board ptn stock news palatin technologies inc ptn ptn ptn stock palatin technologies website next related searches palatin technologies inc rumors ptn stock prediction ptn message board ptn stock news palatin technologies inc ptn ptn ptn stock palatin technologies website search the web  aol inc all rights reservedprivacy   terms of use   preferences   contact us   powered by bing™ wowcom  part of the aol search network palatin technologies  the leader in melanocortinbased therapeutics  drug therapies activating the power of your body palatin technologies develops peptide therapeutics for diseases with significant unmet medical need and commercial potential learn more female sexual dysfunction bremelanotide is an ondemand treatment for the most common type of female sexual dysfunction learn more improving quality of life for patients with heart failure natriuretic peptide mimetics for heart failure providing increased therapeutic options learn more obesity and diabetes peptide therapeutics to help regulate eating behavior and energy balance leading to decreased food intake and weight loss learn more inflammatory diseases using the melanocortin receptor system to help control inflammatory and autoimmune diseases like inflammatory bowel disease nephritis and uveitis learn more   pipeline pipeline status of our clinical and preclinical programs including our inflammatory and heart disease programs learn more investors investors learn about palatin including press releases presentations filings with the securities and exchange commission and more learn more news news the latest news about palatin with the full text of press releases issued by palatin learn more upcoming events upcoming events scheduled presentations by palatin senior management quarterly calls scientific presentations and other upcoming events   learn more corporate presentation corporate presentation palatin’s corporate presentation with an emphasis on bremelanotide for female sexual dysfunction and other pipeline development programs learn more palatin technologies inc  office in cranbury foursquarelog insign upnearbyget inspiredtop pickstrendingfoodcoffeenightlifefunshoppingplanning a trip to new yorkfoursquare can help you find the best places to go tofind great things to dopalatin technologies incofficecranburysavesharetipspalatin technologies incno tips and reviewslog in to leave a tip herepostno tips yetwrite a short note about what you liked what to order or other helpful advice for visitors photorelated searchespalatin technologies inc cranbury  palatin technologies inc cranbury photos  palatin technologies inc cranbury location  palatin technologies inc cranbury address  palatin technologies inc cranbury  palatin technologies inc cranbury  palatin technologies inc cranbury  aboutblogbusinessescitiesdevelopershelpjobscookies updatedprivacy updatedtermsenglishenglish français deutsch bahasa indonesia italiano 語 한국어 português русский español ภาษาไทย türkçe citiesatlantaaustinbostonchicagodallasdenverhoustonlas vegaslos angelesnew yorkphiladelphiaportlandsan diegosan franciscoseattlewashington dccountriesbelgiumbrazilcanadachilefinlandfrancegermanygreat britainhungaryindonesiajapanmexiconetherlandsphilippinesrussiasingaporespainthailandturkeymore great places in cranburyabcdefghijklmnopqrstuvwxyzfoursquare    lovingly made in nyc  sfpalatin technologies incc cedarbrook drcranbury nj united statesget directions see moreunited states » new jersey » middlesex county » cranburyis this your business claim it nowmake sure your information is up to date plus use our free tools to find new customersyou must enable javascript to use foursquarecomwe use the latest and greatest technology available to provide the best possible web experienceplease enable javascript in your browser settings to continuedownload foursquare for your smart phone and start exploring the world around you yelp yelp sorry you’re not allowed to access this page contact yelp if you keep experiencing issues bing places for business bing places for business sign in using your microsoft account work account google account facebook account dont have an account create one